Clinical study on modified Banxia Xiexin decoction in the treatment of simple Obesity in Children

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050510

Enrollment

Unknown

Registered

2021-08-28

Start date

2021-09-01

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Simple obesity in children

Interventions

experimental group:Diet and exercise management+Banxia Xiexin decoction

control group:Diet and exercise management+placebo

Eligibility

Sex/Gender

All

Age

7 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for childhood simple obesity; 2. Aged 7 to 14 years; 3. The legal guardian of the child signed the informed consent; 4. In line with children with simple obesity in children with strong stomach and weak spleen.

Exclusion criteria

Exclusion criteria: 1. Those who have used drug therapy in the past 3 months; 2. Suffering from congenital metabolic or genetic diseases, liver and kidney diseases, infectious diseases such as AIDS and active tuberculosis; 3. Participating in clinical trials of other drugs.

Design outcomes

Primary

Measure	Time frame
Body Mass Index;waist to hip ratio;	—

Secondary

Measure	Time frame
Traditional Chinese Medicine Syndrome Scale;blood sugar;blood fat;insulin;uric acid;	—

Countries

China

Contacts

Public ContactZheng Hong

He'nan University of Traditional Chinese Medicine

drzhenghs@126.com+86 18937153029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026